MAPT and Alzheimer disease: Furthermore, recent developments in the use of high-performance blood tests in clinical practice for accurate AD diagnosis and AD-specific treatments12 make EV P-tau levels less interesting as a diagnostics tool, as using CSF is more invasive than plasma.